Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#C-Reactive Protein Testing Market Growth Potential: How Will Market Size Shift Through 2030?#_x000D_
The c-reactive protein testing market size has experienced robust expansion in recent years. Projections indicate that this market will expand from $3.52 billion in 2025 to $3.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. Historically, this growth has been driven by factors such as the increasing incidence of inflammatory conditions, the growing application of CRP testing in clinical diagnosis, the development of hospital laboratory infrastructure, heightened awareness regarding early disease identification, and the availability of uniform assay kits._x000D_
_x000D_
The c-reactive protein testing market size is anticipated to show consistent expansion in the coming years. It will grow to $4.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The factors contributing to this growth during the forecast period include the increasing demand for point-of-care inflammatory testing, the rising integration of automated diagnostics platforms, the expansion of preventive healthcare screening, the growing adoption of high-throughput laboratory systems, and an increasing focus on personalized medicine diagnostics. Significant trends for the forecast period involve the increasing adoption of high-sensitivity CRP assays, the rising use of automated immunoassay systems, the growing demand for rapid inflammation diagnostics, the expansion of CRP testing in cardiovascular risk assessment, and an enhanced focus on laboratory workflow automation._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#C-Reactive Protein Testing Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The rising incidence of cardiovascular diseases (CVD) is projected to fuel the expansion of the c-reactive protein testing market. These diseases encompass various heart conditions, including impaired vessels, structural abnormalities, and blood clots. While the precise etiology of CVD remains unclear, several factors are known to elevate the risk of its development. A significant contributor is behavioral risk, stemming from poor dietary habits, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis), subsequently increasing the likelihood of blood clots. Such behavioral patterns contribute to heightened blood pressure, elevated glucose and blood lipid levels, weight gain, and obesity. The growing prevalence of cardiovascular diseases necessitates c-reactive protein testing to effectively diagnose or forecast the probability of cardiovascular issues, performing at least as well as cholesterol level assessments. For example, data from October 2024, provided by the Centers for Disease Control, a US-based government agency, indicated that in 2023, approximately 919,032 people succumbed to cardiovascular disease, representing 1 in every 3 deaths. Consequently, the escalation in cardiovascular diseases (CVD) cases is a key driver for the C-reactive protein testing market._x000D_
_x000D_
#C-Reactive Protein Testing Market Segment Performance And Emerging Opportunities#_x000D_
The c-reactive protein testing market covered in this report is segmented – _x000D_
_x000D_
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays_x000D_
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications _x000D_
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories_x000D_
_x000D_
Subsegments:_x000D_
1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA _x000D_
2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems _x000D_
3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays _x000D_
_x000D_
#C-Reactive Protein Testing Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading entities within the C-reactive protein testing market are concentrating on creating advanced technological solutions, specifically high-sensitivity automated immunoassays. These innovations aim to achieve improved accuracy, quicker results, and the detection of even minute CRP levels, which is crucial for early cardiovascular risk stratification and continuous inflammation monitoring. Such high-sensitivity automated immunoassays employ sophisticated immunoturbidimetric or nephelometric methods to identify extremely low CRP concentrations, significantly lower than what standard CRP assays can achieve, thereby facilitating prompt intervention and enhanced prognostic assessment. An illustrative example is the launch of the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay by Siemens Healthineers, a Germany-based in vitro diagnostics firm, in January 2024, designed for their Atellica CH Analyzer. This product consists of two ready-to-use reagent packs; one contains a phosphate buffer with surfactant, while the other holds monoclonal anti-CRP antibodies attached to polystyrene particles. The presence of CRP in a patient sample induces the aggregation of these particles, leading to a measurable light scattering event, where the intensity directly correlates with the CRP concentration. This system effectively detects very low-level CRP for cardiovascular risk stratification, is compatible with serum or plasma samples, and provides rapid quantitative results, aiding in prompt clinical decision-making._x000D_
_x000D_
#C-Reactive Protein Testing Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the c-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation _x000D_
_x000D_
#View The Full C-Reactive Protein Testing Market Report:#_x000D_
_x000D_
#C-Reactive Protein Testing Market Global Footprint: Which Region Leads The Industry?#_x000D_
North America was the largest region in the c-reactive protein testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.